Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Arnaud Trebucq"'
Autor:
Jean Claude Semuto Ngabonziza, Awa Ba Diallo, Elisa Tagliani, Bassirou Diarra, Abalo Essosimna Kadanga, Antieme Combo George Togo, Aliou Thiam, Willem Bram de Rijk, Riccardo Alagna, Sabine Houeto, Fatoumata Ba, Anoumou Yaotsè Dagnra, Emil Ivan, Dissou Affolabi, Valérie Schwoebel, Arnaud Trebucq, Bouke Catherine de Jong, Leen Rigouts, Géraldine Daneau, “Union short MDR-TB regimen study group”
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0187211 (2017)
Besides inclusion in 1st line regimens against tuberculosis (TB), pyrazinamide (PZA) is used in 2nd line anti-TB regimens, including in the short regimen for multidrug-resistant TB (MDR-TB) patients. Guidelines and expert opinions are contradictory a
Externí odkaz:
https://doaj.org/article/8ba3bf05f6a04070aad504423497ccab
Autor:
Géraldine Daneau, Mourad Gumusboga, Pim De Rijk, Arnaud Trebucq, Leen Rigouts, Armand Van Deun, Bouke C de Jong
Publikováno v:
International Journal of Mycobacteriology, Vol 5, Iss 5, Pp 46-47 (2016)
Objective/Background: Pyrazinamide (PZA) is an antibacterial used in the first-line regimen against tuberculosis (TB) for its action against dormant bacilli. PZA is also included in the new short regimen to treat multidrug-resistant TB (MDR-TB). Howe
Externí odkaz:
https://doaj.org/article/b49e9ff7854043fc9fb96689df33753d
Autor:
Eric Delaporte, Nicole Monplaisir, Joost Louwagie, Martine Peeters, Yves Martin-Prével, Jean-Paul Louis, Arnaud Trebucq, Léonard Bedjabaga, Simon Ossari, Cécile Honoré, Bernard Larouzé, Luc d'Auriol, Guido Van DerGroen, Peter Piot
Publikováno v:
International Journal of Cancer. 49:373-376
A cluster sampling survey was performed in 1989 in Libreville, Gabon, to determine HTLV-I and HTLV-II prevalence and to compare the efficacy of polymerase chain reaction (PCR) and serology in detecting HTLV-I and HTLV-II infections. A total of 322 se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2299885c069f17a956750c9d8e2b1e4f
https://doi.org/10.1002/ijc.2910490310
https://doi.org/10.1002/ijc.2910490310
Autor:
Valérie Schwœbel, Arnaud Trébucq, Zacharie Kashongwe, Alimata S. Bakayoko, Christopher Kuaban, Juergen Noeske, Souleymane H. Harouna, Mahamadou B. Souleymane, Alberto Piubello, François Ciza, Valentin Fikouma, Michel Gasana, Martial Ouedraogo, Martin Gninafon, Armand Van Deun, Elisa Tagliani, Daniela M. Cirillo, Kobto G. Koura, Hans L. Rieder
Publikováno v:
EClinicalMedicine, Vol 20, Iss , Pp - (2020)
Background: Treatment outcomes of the shorter regimen for rifampicin-resistant tuberculosis are not completely established. We report on these outcomes two years after treatment completion among patients enrolled in an observational cohort study in n
Externí odkaz:
https://doaj.org/article/5ef7adc6d97a49b6a696aab540072424
Autor:
Serge Ade, Anthony D Harries, Arnaud Trébucq, Gabriel Ade, Gildas Agodokpessi, Christine Adjonou, Sophie Azon, Sévérin Anagonou
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95603 (2014)
BackgroundIn sub-Saharan Africa, there is a dearth of published literature on extrapulmonary tuberculosis (EPTB).ObjectiveTo describe demographic, diagnostic and HIV-status characteristics of patients with EPTB in Bénin, their treatment outcomes, an
Externí odkaz:
https://doaj.org/article/278c052d62c340ddb24afa27d5010d89